Krystal Biotech, Inc. KRYS Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s operating margin?
- Krystal Biotech, Inc. (KRYS) reported operating margin of 42.8% in Q1 2026.
- How has Krystal Biotech, Inc.'s operating margin changed year-over-year?
- Krystal Biotech, Inc.'s operating margin increased by 31.4% year-over-year, from 32.6% to 42.8%.
- What is the long-term trend for Krystal Biotech, Inc.'s operating margin?
- Over 2 years (2023 to 2025), Krystal Biotech, Inc.'s operating margin has grown at a -56.9% compound annual growth rate (CAGR), from -222.6% to 41.4%.
- What does operating margin mean?
- The profit left from core operations for every dollar of sales, before interest and taxes.
- How do you interpret operating margin?
- Expanding operating margin shows operating leverage — revenue growing faster than the cost base. Compression points to rising overhead, pricing pressure, or investment ahead of revenue.
- How does operating margin compare across companies?
- Strong cross-company signal within a sector. Capital-light businesses sustain higher operating margins than capital-intensive ones.